Stocksigma LogoStocksigma Logo

iSERA Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

■ Revenue: 0.0 ■ EBITDA: -20.3 (-6656.7% YoY | +39.7% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -13.1 (Profit to Loss YoY | +61.0% QoQ) ■ EPS (INR): -0.62

iSERA Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

iSERA Lifesciences Ltd · Outcome · 04 Nov 2026, 11:06 pm

iSERA Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -20.3 (-6656.7% YoY | +39.7% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -13.1 (Profit to Loss YoY | +61.0% QoQ) ■ EPS (INR): -0.62 (Profit to Loss YoY | +61.3% QoQ)

Original exchange filing (PDF)

More announcements from iSERA Lifesciences Ltd

All iSERA Lifesciences Ltd announcements